September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Intravitreal Administration of Human Bone Marrow CD34+ Stem Cells in a Murine Model of Retinal Degeneration
Author Affiliations & Notes
  • Elad Moisseiev
    Department of Ophthalmology, UC Davis Eye Center, Davis, California, United States
  • Zeljka Smit-McBride
    Vitreoretinal Research Laboratory, UC Davis, Davis, California, United States
  • Sharon Oltjen
    Vitreoretinal Research Laboratory, UC Davis, Davis, California, United States
  • Pengfei Zhang
    RISE Eye-Pod Laboratory, UC Davis, Davis, California, United States
  • Robert J Zawadzki
    RISE Eye-Pod Laboratory, UC Davis, Davis, California, United States
  • Monica Motta
    Department of Surgical and Radiological Sciences, School of Veterinary Medicine, UC Davis, Davis, California, United States
  • Christopher J Murphy
    Department of Surgical and Radiological Sciences, School of Veterinary Medicine, UC Davis, Davis, California, United States
  • Whitney Cary
    Stem Cell Program, Institute for Regenerative Cures, UC Davis, Sacramento, California, United States
  • Geralyn Annett
    Stem Cell Program, Institute for Regenerative Cures, UC Davis, Sacramento, California, United States
  • Jan Nolta
    Stem Cell Program, Institute for Regenerative Cures, UC Davis, Sacramento, California, United States
  • Susanna S Park
    Department of Ophthalmology, UC Davis Eye Center, Davis, California, United States
  • Footnotes
    Commercial Relationships   Elad Moisseiev, None; Zeljka Smit-McBride, None; Sharon Oltjen, None; Pengfei Zhang, None; Robert Zawadzki, None; Monica Motta, None; Christopher Murphy, None; Whitney Cary, None; Geralyn Annett, None; Jan Nolta, None; Susanna Park, None
  • Footnotes
    Support  1. Some funds used for this study were received from the Foundation Fighting Blindness. These funds were not a grant or support given specifically for the purpose of this study. 2. ZSM is funded by the Barr Foundation at UC Davis. This too was not a grant or support given specifically for the purpose of this study.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 6068. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Elad Moisseiev, Zeljka Smit-McBride, Sharon Oltjen, Pengfei Zhang, Robert J Zawadzki, Monica Motta, Christopher J Murphy, Whitney Cary, Geralyn Annett, Jan Nolta, Susanna S Park; Intravitreal Administration of Human Bone Marrow CD34+ Stem Cells in a Murine Model of Retinal Degeneration. Invest. Ophthalmol. Vis. Sci. 2016;57(12):6068.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Autologous intravitreal bone marrow CD34+ hematopoietic cells are being explored in a human clinical trial as potential therapy for retinal degeneration (registered with clinicaltrials.gov, NCT01736059). Since urine CD34+ cells are not comparable to human CD34+ cells, the purpose of this study was to examine the effect of intravitreal human CD34+ cells in a murine model of hereditary retinal degeneration, in order to further characterize the effects of these human cells on the degenerating retina.

Methods : C3H/HeJ mice, homozygous for the rd1 mutation and systemically immunosuppressed, were treated with an intravitreal injection of either PBS (n=16) or CD34+ cells (n=16) isolated from human bone marrow and labeled with EGFP. The treated eyes were imaged in vivo with simultaneous SLO/OCT retinal imaging to localize the EGFP labeled cells in the eye. ERG testing was conducted on both eyes. Animals were euthanized and the eyes were harvested for immunohistochemical and microarray analysis of the retina.

Results : In vivo SLO fundus imaging allowed visualization of EGFP labeled cells within the eyes following intravitreal injection of CD34+. Simultaneous b-scan OCT analysis of the corresponding retina localized the EGFP labeled cells on the retinal surface. Immunohistochemical analysis of the retina identified EGFP labeled cells on the retinal surface. Phase contrast microscopy visualized the cells adjacent to the ganglion cells and the internal limiting membrane. ERG showed a flat signal both at 1 and 4 weeks following injection in both eyes in all mice. Microarray analysis of the retina showed significant alteration in expression of >300 mouse genes in CD34+ stem cell treated eyes, with predominant effects on genes in pathways regulating phototransduction, photoreceptor development and maintenance, and apoptosis.

Conclusions : Intravitreal injection of human CD34+ stem cells from bone marrow resulted in their intraocular survival and localization directly on top of the retina. Although the effect of this cell therapy on retinal function could not be appreciated in this murine model of rapidly progressive retinal degeneration, the molecular changes in the retina associated with human CD34+ cell therapy suggest potential paracrine trophic regenerative effects on the degenerating retina that warrant further exploration.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×